Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, Fyn, YES1) and BTK, which are essential for B-cell receptor (BCR) ...
Skincare at 30 is about choosing what works, with hydration, sunscreen, and a few smart splurges that make an anti-aging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results